Prosight Management LP 13D and 13G filings for ADC Therapeutics SA:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 08:58 am Sale | 2024-09-30 | 13G | ADC Therapeutics SA ADCT | Prosight Management LP | 9,617,531 9.950% | -9,486 (-0.10%) | Filing |
| 2024-11-13 08:30 am Purchase | 2024-09-30 | 13G | ADC Therapeutics SA ADCT | Prosight Management LP | 9,627,017 9.960% | 3,155,217 (+48.75%) | Filing |
| 2024-02-13 09:47 am Purchase | 2023-12-31 | 13G | ADC Therapeutics SA ADCT | Prosight Management LP | 6,471,800 8.000% | 2,167,282 (+50.35%) | Filing |
| 2023-04-14 5:45 pm Purchase | 2023-04-06 | 13G | ADC Therapeutics SA ADCT | Prosight Management LP | 4,304,518 5.300% | 4,304,518 (New Position) | Filing |